Oral Medicine Center Switzerland

18 hours + of live discussion sessions
26 live clinico-pathological cases and oral presentations on research
Available for 180 days
Register now

The past 2 years have been very challenging as the world has responded to the COVID-19 pandemic. Despite the challenges, it has also been a period of innovation and EAOM adapted to these world-changing events by delivering a 2021 Congress that is fully digital.

This decision makes our congress even more international and accessed by the global Oral Medicine community. In keeping with this all sessions will be recorded, and the material will be available on-line for up to 180 days following the meeting, including around 200 Posters and Oral Presentations.

The Meeting is well advanced and like all EAOM events it will showcase scientific content of the highest standard with top-quality production and latest technologies presentation that our congress technical team is deploying. Viagra kan het wonder zijn waarnaar je op zoek was - gwinnetthealth.org

We are delighted to welcome you to our EAOM 2021 E-Congress, and we look forward to sharing our exciting and engaging programme with our colleagues and friends. Kamagra 100mg, what it is and what it does and how to use it .

Kind regards

António Mano Azul and Luis Monteiro
Chair and Co-Chair Local Organising Committee

 

Schedule on GMT Time (Portugal and UK +1, CET +2)


  • DAY 1 (FRIDAY, 24TH SEPTEMBER)

    Time Topic - ROOM 1 Topic - ROOM 2
    08h00 - 08h15 Congress Opening
     • Nikolaos Nikitakis (President EAOM) and Antonio Azul (Chair Local Organizing Committee)
    		  
    08h15 - 09h00 “Crispian Scully Lecture” by Peter A. Brennan (UK)
     • Human factors - the art of applying common sense at work when treating oral cancer    		  
    09h00 - 13h00

    09h00 - 13h00
    OPMD and oral cancer
    Moderators: Antonio Azul and Saman Warnakulasuriya

     • 09h00 - The public health program for oral cancer detection in Portugal – Pedro Trancoso (Portugal)
     • 09h25 - Screening for OPMDs and oral cancer – Giovanni Lodi (Italy)
     • 09h50 - Adjunctive tools in the diagnosis of OPMD with a focus on contact endoscopy – Luis Monteiro (Portugal)
     • 10h15 - Risk stratification of oral leukoplakia – Saman Warnakulasuriya (UK)

     • 10h40 - 11h00: Break

     • 11h00 - Oral lichen planus as an oral potentially malignant disorder – Miguel Gonzales Moles (Spain)
     • 11h30 - Sentinel lymph node biopsy in the management of oral cancer – Abel Garcia (Spain)
    • 12h15 - Discussion

    09h00 - 11h00
    Medically compromised patients. New insights in...
    Moderators: Pedro Diz Dios and Konstantina Delli

     • 09h00 - ...dental management of solid organ transplant patients – Jukka Meurman (Finland)
     • 09h25 - ...dental management of patients with head and neck cancer – Marcio Diniz-Freitas (Spain)
     • 09h50 - ...oral features of rheumatic diseases – from disease activity to drug adverse events – Luis Gueiros (Brazil)
     • 10h15 - ...antibiotic prophylaxis prescribing for medically compromised patients undergoing invasive dental procedures – Martin Thornhill (UK)
     • 10h35 - ...the association between periodontal disease and diabetes – Francesco D’Aiuto (UK)

     • 11h00 - 11h15: Coffee Break

    11h15 -     13h15
    Oral Presentations (research)
    Moderators: Michael Escudier and Filipe Freitas

     • 11h15 - Development of a multi-cellular tissue engineered model of oral lichen planus - Asma Muftah Mohamed El Howati (UK)
     • 11h30 - Expression profiling of miRNAs in Oral Lichen Planus - Heba Mousa Ali (UK)
     • 11h45 - Predicting malignant progression in oral potentially malignant disorders by DNA ploidy analysis: a prospective study comparing oral leukoplakia and proliferative verrucous leukoplakia - Monica Pentenero (Italy)
     • 12h00 - Next-Generation Sequencing Profiles of the RNA Transcriptome in Peripheral Blood Mononuclear Cells in Young Female Patients with Temporomandibular Joint Osteoarthritis: possible contribution of immunological dysfunction - Jeong-Hyun Kang (Republic of Korea)
     • 12h15 - Expression of pancreatic transcription factors by minor salivary gland stem cells. A challenge for insulin-secreting b-cell lineage trans-differentiation.- Dimitrios Andreadis (Greece)
     • 12h30 - Oral cancer prediction by noninvasive genetic screening - Jos Poell (the Nederlands)
     • 12h45 - The genetic profile of oral leukoplakia and its relation to malignant progression. - Leon Wils (the Nederlands). Zithromax 500mg - Avete un'infezione batterica che non sembra andare via?
     • 13h00 - Mucosal immune response in BNT162b2 COVID-19 vaccine recipients - Lorenzo Azzi (Italy)

    10 min presentation + 5 min discussion
    13h00/14h00 13h00 - 14h00 - Lunch Break 13h00 - 14h00- Lunch Break
    14h00 - 17h00

    Immune mediated oral diseases
    Moderators: Marco Carrozzo and Jairo Robledo

     • 14h00 - Immunobiologic therapy for MMP – Michele Mignogna (Italy)
     • 14h25 - Immunobiologic therapy for PV– Jane Setterfield (UK)
     • 14h50 - Oral microbiome and immune-mediated oral diseases : Aphtous stomatitis – Karolin Hijazi (UK)

     • 15h15 - 15h45: Coffee Break

     • 15h45 - Microbiome in Sjogren's syndrome – Arjan Vissink ( the Netherlands)
     • 16h10 - Current concepts in the topical treatment of OLP – Nathaniel Treister (USA)
     • 16h35 - Current concepts in the systemic treatment of OLP – Marco Carrozzo (UK)

      • 17h00 - Discussion

    Clinical Pathological Session
    Moderators: Marco Meleti and Pedro Trancoso

    • 14h00 - Case 1. Intra/extraoral swelling. Contributor: Arvind Muthukrishnan (India) – Discussant: Ronell Bologna-Molina (Uruguay).
    • 14h20 - Case 2. Gingival enlargement. Contributor: Umberto Romeo (Italy) – Discussant: Vasilis Theofilou (Greece)
    • 14h40 - Case 3. Gingival ulcerations. Contributor: Kıvanç Bektaş Kayhan (Turkey) - Discussant: Ana Carolina Fragoso Motta (Brazil)
    • 15h00 - Case 4. White and red patches/erosions. Contributor: Andrea Maria Schmidt-Westhausen (Germany) - Discussant: Stefania Leuci (Italy))
    • 15h20 - Case 5. Erythemathous gingival lesion. Contributor: Rosa María López Pintor Muñoz (Spain) – Discussant: Maria Georgaki (Greece)
    • 15h40 - Case 6. Palatal ulceration. Contributor: Amanda Willis (United Kingdom) - Discussant: Monika Schwaninger (Austria)
    • 16h00 - Case 7. White and red patches. Contributor: Maria Bankvall (Sweden) – Discussant: Jumana Karasneh (Jordan)
    • 16h20 - Case 8. Oral swelling. Contributor: Karin Garming-Legert (Sweden) – Discussant: Sangeetha Yogarajah (United Kingdom)

     

     • 16h40 - Discussion

     

     

     
    Time Topic - ROOM 3 Topic - ROOM 4
    24h/24h

    Oral Presentations (Research and Clinical) 24h/24h

    Poster Presentations 24h/24h

  • DAY 2 (SATURDAY, 25TH SEPTEMBER)

    Time Topic - ROOM 1 Topic - ROOM 2
    08:00 h. - 11:00 h.

    08h00 - 11h00.
    Molecular aspects of oral leucoplakia and their influence on its diagnosis and management
    Moderators: Camile Farah and Barbara Carey

     • 08h00 - Prognostic biomarkers of oral leukoplakia: evidence and outcomes from systematic reviews. - Antonio Celentano (Australia)
     • 08h25 - Correlation between molecular markers and histopathological features of oral leukoplakia. - Nikolaos Nikitakis (Greece)
     • 08h50 - Diagnostic microRNA profile of oral leukoplakia. - Tami Yap (Australia)
     • 09h15 - Molecular biomarkers of malignant transformation in oral leukoplakia. - Michael McCullough (Australia)
     • 09h40 - Salivary metabolomics and oral leukoplakia. - Marco Meleti (Italy)
     • 10h05 - Exomic and transcriptomic profile of oral leukoplakia; have we arrived at a paradigm shift? - Camile Farah (Australia)

    08h00 - 11h00.
    Oral presentations (clinical)
    Moderators: Antonio Azul and Athanasios Poulopoulos

     • 08h00 - Paraneoplastic mucous membrane pemphigoid - Sangeetha Yogarajah (UK)
     • 08h15 - Assessment of patient-clinician agreement on information needs about oral epithelial dysplasia - Abdullah Alsoghier (UK)
     • 08h30 - Burning-fog: Cognitive impairment in Burning Mouth Syndrome - Daniela Adamo (Italy)
     • 08h45 - Lesion-related determinants for surgical treatment of oral leukoplakia: Oral Medicine Practitioners’ attitudes - Samuele Sutera (Italy)
     • 09h00 - A service evaluation of treatment of erosive oral lichen planus at Newcastle Dental Hospital - Samuel McCarthy (UK)
     • 09h15 - Patterns and predictors of recurrence in oral leukoplakia: An immunohistochemical study - Maria Georgaki (Greece)
     • 09h45 - Salivary Gland Hypofunction and/or Xerostomia Induced by Non-Surgical Cancer Therapies: ISOO/MASCC/ASCO Guideline - Valeria Mercadante (UK)
     • 10h00 - The development of Proliferative Verrucous Leukoplakia on a background of Oral Lichen Planus: A case series - Caroline McCarthy (UK)
     • 10h15 - Cheilitis Glandularis: A series of 14 cases with emphasis on etiopathogenesis. - Evangelia Piperi (Greece)

    10 min presentation + 5 min discussion

     
    10:45 h. - 11:00 h. Break Break
    11:00 h. - 13:00 h. General Assembly of the EAOM Room closed
      13:00h - 14h00 Lunch Break 13h00 - 15h00 Lunch Break
    14:00h.

    14h00 - 15h30
    European Cooperation Clinical Research
    Moderators: Camile Farah and Barbara Carey

     • 14:00h - Multicentre Clinical studies: the good, the bad and the ugly – Stefano Fedele (UK)
     • 14:25h - The design, funding, setting-up and delivery of Pan-European collaborative research – Andy Wolff (Israel)
     • 14:50h - Global clinical trials in Oral Medicine: how it is done by the Industry. Lars Siim Madsen, Chief Operating Officer, Afyx Therapeutics (Denmark).
     • 15:15h - Discussion

    • 15:35 h - 16h00: Coffee Break

     16h00 - 17h30
    Panel on Global Cooperation in Oral Medicine
    Moderators: Nikolaos Nikitakis and Luis Monteiro

     • 16:00 - Nikolaos G. Nikitakis (EAOM President)
     • 16:10 - Andres Pinto (AAOM President)
     • 16:20 - Fabio Pires (AIPMB President)
     • 16:30 - Arwa Farag (WWOM Representative)
     • 16:40 - Ramesh Balasubramaniam (OMAA President)

     • 16:50 - 17:30 Discussion Panel:
    Our Guest Speakers and Marco Carrozzo (Past EAOM President), Michael Escudier (EAOM President Elect), Jairo Robledo (EAOM Secretary-General), Antonio Mano Azul and Luis Monteiro (Chair and Co-Chair Local Organizing Committee)

    15h00 - 17h30
    Systemic diseases and the mouth
    Moderators: Michael Escudier and Stephen Flint

     • 15:00h - Oral side effects of various systemic medications – Michael Escudier
     • 15:25h - Medication-related osteonecrosis of the jaws – Paolo Vescovi (Italy)

     • 15:50 h - 16h15: Coffee Break

     • 16:15h - Covid 19 : Implications for Oral Medicine – Stephen Porter (UK)
     • 16:40h - Oral complications of antineoplastic treatment - Sook-Bin Woo (USA)


     • 17:05h - 17h20 - Discussion
    17:30 h. Next EAOM meeting presentation  
    17:45 h. Closing of the Congress - Awards  
    Time Oral Presentations - ROOM 3 Posters - ROOM 4
    24 h/24 h.

    Oral Presentations (Research and Clinical) 24h/24 hours

    Poster Sessions 24h/24 hours
  • 1